Public research preview
Thomas Suozzi, Representative disclosure: ew Bristol-Myers Squibb Company Common Stock (BMY)
Disclosed a sell transaction in ew Bristol-Myers Squibb Company Common Stock (BMY). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 19 Dec 2022, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 560 days
Timeline
Transaction date
7 Jun 2021
Public disclosure
19 Dec 2022
Now
Tracked today
Filing delay: 560 days
Price movement
Fallback coverage
- Provider
- Fixture market data
- Fetched
- 26 May 2026
No free fixture-market price coverage for unknown ISIN / BMY.
Daily stock-price history is unavailable for this signal.
- Fallback transaction price
- Not available
- Fallback disclosure price
- Not available
- Fallback latest price
- Not available
- Pre-disclosure move
- Not available
- Post-disclosure move
- Not available
- Market-adjusted move
- Not available
Why Copy Window is Probably too late
Supporting factors
- Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
- Transaction value is 0.
- Post-disclosure move is calculated from Fixture market data daily closes.
Cautions
- Market-price coverage is fixture-backed until a free public provider is connected.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 19 Dec 2022, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%